The WHO Guidelines recommend HPV detection via molecular test after age of 30 (and every 5 years thereafter). Vaccination against HPV is highly recommended for younger people under the age of 15 or before the initiation of sexual activity.
Do not leave equity behind
"Truenat HPV-HR Plus test is about equity in detection. By expanding beyond traditional targets, we reach the genotypes that matter more in our populations for cervical cancer elimination. This means earlier intervention, fewer missed cases, and better outcomes," said Dr Sachdeva. Truenat HPV-HR Plus offers the best of both worlds - critical genotype coverage and real-world deploy-ability.
What does it mean to eliminate cervical cancer by 2030?
To eliminate cervical cancer, all countries must reach and maintain an incidence rate of below 4 per 100,000 women. Achieving that goal rests on three key pillars and their corresponding targets:
vaccination: 90% of all eligible young people must be fully vaccinated with the HPV vaccine by the age of 15.
screening: 70% of women should be screened using a high-performance test by the age of 35, and again by the age of 45;
treatment: 90% of women with pre-cancer treated and 90% of women with invasive cancer managed.
No other cancer but cervical cancer is fully preventable and curable if detected and managed early. Even one death from it is a death too many.
Shobha Shukla - CNS (Citizen News Service)
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
